You are here

Use of Antiaromatases in the Elderly Task Force

The task force aims to establish expert recommendations on the treatment of patients beyond 65 suffering from hormone sensitive early breast cancer, and to describe adjuvant hormonal treatment options and their known short and long term side effects in this patient population.

Task Force Members

Chair: Matti Aapro, Switzerland
Diana Crivellari, Italy
Nicolai Maass, Germany
Alain Monnier, France
Hans Nortier, Netherlands
Jean-Philippe Spano, France
Beat Thürlimann, Switzerland

This project was supported by an unrestricted grant from Pfizer.